Relative value of allogeneic BMT, autologous BMT and intensive chemotherapy during the first complete remission (CR) of acute myelogenous leukemia (AML). An interim analysis of the AML8 EORTC-GIMEMA protocol.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples